Extremely frustrating!!!! Surely the timeline a pharma company would be pretty excited about getting onboard……Especially now with the current situation, the fact I’m still not convinced of Pfizer’s antiviral with the rebound and all. How will Pfizer’ s antiviral fair up against these new Onicron variant’s???? To many unknowns still associated with this Pandemic, hence Bit225 on the Covid front should now be fully funded or better still a commercial deal.
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-469
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
